cytochrome P450, family 2, subfamily s, polypeptide 1
RGD ID:
1306078
Description:
Predicted to enable several functions, including heme binding activity; monooxygenase activity; and thromboxane-A synthase activity. Predicted to be involved in monocarboxylic acid metabolic process and xenobiotic metabolic process. Predicted to be located in endoplasmic reticulum. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Orthologous to human CYP2S1 (cytochrome P450 family 2 subfamily S member 1); PARTICIPATES IN phase I biotransformation pathway via cytochrome P450; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3-methylcholanthrene; atrazine.
[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Aflatoxin B1 and [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Aflatoxin B1
[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Tretinoin and [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Tretinoin
[[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-1 more ...
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP2S1 mRNA
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP2S1 mRNA
[CYP2S1 protein results in increased reduction of Hydroxylamine] which results in increased chemical synthesis of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole